These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18949516)

  • 1. Alveolar exhaled nitric oxide is elevated in hereditary hemorrhagic telangiectasia.
    Gupta S; Zamel N; Faughnan ME
    Lung; 2009; 187(1):43-9. PubMed ID: 18949516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations.
    de Picciotto C; El Hajjam M; Karam C; Chinet T; Bonay M
    Respir Res; 2019 Jul; 20(1):137. PubMed ID: 31272464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Transcranial Doppler for Detecting Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.
    Kijima Y; Gevorgyan R; McWilliams JP; Miller N; Noureddin N; Tobis JM
    Am J Cardiol; 2016 Apr; 117(7):1180-4. PubMed ID: 26873746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated circulating microRNA-210 levels in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: a potential new biomarker.
    Zhang Q; Kandic I; Faughnan ME; Kutryk MJ
    Biomarkers; 2013 Feb; 18(1):23-9. PubMed ID: 23051042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple pulmonary arteriovenous malformations associated with hereditary hemorrhagic telangiectasia].
    Terata Y; Shioya T; Watanabe H; Sano M; Kagaya M; Watanabe A; Kashima M; Ito T; Sato K; Sasaki M; Miura M; Miura S; Sudo M; Hozumi H
    Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):915-21. PubMed ID: 18217315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).
    Cottin V; Dupuis-Girod S; Lesca G; Cordier JF
    Respiration; 2007; 74(4):361-78. PubMed ID: 17641482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.
    Lehtonen H; Oksa P; Lehtimäki L; Sepponen A; Nieminen R; Kankaanranta H; Saarelainen S; Järvenpää R; Uitti J; Moilanen E
    Thorax; 2007 Jul; 62(7):602-7. PubMed ID: 17251310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview.
    Lacombe P; Lacout A; Marcy PY; Binsse S; Sellier J; Bensalah M; Chinet T; Bourgault-Villada I; Blivet S; Roume J; Lesur G; Blondel JH; Fagnou C; Ozanne A; Chagnon S; El Hajjam M
    Diagn Interv Imaging; 2013 Sep; 94(9):835-48. PubMed ID: 23763987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary capillary hemangiomatosis arising in hereditary hemorrhagic telangiectasia.
    Varnholt H; Kradin R
    Hum Pathol; 2004 Feb; 35(2):266-8. PubMed ID: 14991548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome.
    Foresi A; Leone C; Olivieri D; Cremona G
    Chest; 2007 Sep; 132(3):860-7. PubMed ID: 17646233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.
    Ryan DJ; O'Connor TM; Murphy MM; Brady AP
    Clin Radiol; 2017 Mar; 72(3):236-241. PubMed ID: 28040200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine.
    Post MC; Letteboer TG; Mager JJ; Plokker TH; Kelder JC; Westermann CJ
    Chest; 2005 Oct; 128(4):2485-9. PubMed ID: 16236913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and nature of dyspnea in patients with hereditary hemorrhagic telangiectasia (HHT).
    Rozenberg D; Leek E; Faughnan ME
    Respir Med; 2015 Jun; 109(6):768-77. PubMed ID: 25940942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.
    Shovlin CL; Jackson JE; Bamford KB; Jenkins IH; Benjamin AR; Ramadan H; Kulinskaya E
    Thorax; 2008 Mar; 63(3):259-66. PubMed ID: 17981912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations.
    Krishnan S; Lahm T
    Medicine (Baltimore); 2018 Aug; 97(32):e11513. PubMed ID: 30095617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determining the alveolar component of nitric oxide in exhaled air: procedures and reference values for healthy persons].
    Fortuna AM; Balleza M; Calaf N; González M; Feixas T; Casan P
    Arch Bronconeumol; 2009 Mar; 45(3):145-9. PubMed ID: 19286114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg.
    Gelb AF; Taylor CF; Simmons M; Shinar C
    Pulm Pharmacol Ther; 2009 Dec; 22(6):516-21. PubMed ID: 19467341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin as possible therapy of pulmonary arterio venous malformation in HHT patients.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Med Hypotheses; 2015 Sep; 85(3):245-8. PubMed ID: 25981877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia.
    Verkerk MM; Shovlin CL; Lund VJ
    Rhinology; 2012 Sep; 50(3):277-83. PubMed ID: 22888484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide as a marker of lung involvement in Crohn's disease.
    Malerba M; Ragnoli B; Buffoli L; Radaeli A; Ricci C; Lanzarotto F; Lanzini A
    Int J Immunopathol Pharmacol; 2011; 24(4):1119-24. PubMed ID: 22230422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.